Psychedelic Patents – The Cat’s Out of the Bag
Patents on Psychedelics are No Longer a Novel Idea In January of 2020, we published an article about “Psychedelic Investment Opportunities,” in which reiterated our earlier position (from 2019) that …
Psychedelic Investment Opportunities – 2020 Perspective
Investing in psychedelics (e.g., magic mushrooms, psilocybin, etc.) has became a hot topic during 2019. Following Peter Thiel’s investment in Compass Pathway in 2018, several high-profile investors entered the psychedelic …
American Chemical Society Meeting – Only One Talk about Psychedelics?
The upcoming 2019 American Chemical Society (“ACS”) Fall Meeting and Exposition in San Diego features two presentations pertaining to psychedelic chemistry: (1) a talk by Dr. David Manke and Dr. …
Review of the State of the Art for Microdosing Psychedelics
As of July 2019 the state of the art for microdosing psychedelics is best described as a collection anecdotal reports from people taking unknown amounts of unknown drugs at wildly …
Why Formulations are Better than Mushrooms
Formulations made from magic mushrooms offer some advantages over mushroom fruiting bodies or natural preparations. We previously discussed the analogy between cannabis and magic mushrooms. Both cannabis and magic mushrooms …
Compass Pathways’s Patents
In late April of 2019, both the United States Patent and Trademark Office (“USPTO”) and the World Intellectual Property Office (“WIPO”) published Compass Pathways’s Patent Applications directed to psilocybin technology. …
Investing in Psychedelics, Psilocybin, or Magic Mushrooms
** See also recent article on “Investing in Psychedelics – a 2020 Perspective” ** [Updated December 2019] Are magic mushrooms (or psilocybin) going to be the next big investment opportunity …
Rolling Stone: The Future of Cannabis is Formulations of Cannabinoids
Madison Margolin recently published an article in Rolling Stone Magazine explaining that the future of cannabis technology will center around formulated products that eliminate the inherent variability of natural cannabis. …
No Magic Mushroom Monopoly
No Magic Mushroom Monopoly Relax. No one is trying to monopolize magic mushrooms. COMPASS Pathways is not trying to monopolize magic mushrooms. Renewed interest in psychedelic medicine (e.g., psilocybin) is not part …
Cost of Psilocybin
Cost of Psilocybin How much should psilocybin cost — per gram and per dose? With the renewed interest in psilocybin, some have questioned whether commercial involvement will impede access to …